ES2139588T3 - Derivado de ciclopropano. - Google Patents

Derivado de ciclopropano.

Info

Publication number
ES2139588T3
ES2139588T3 ES92301802T ES92301802T ES2139588T3 ES 2139588 T3 ES2139588 T3 ES 2139588T3 ES 92301802 T ES92301802 T ES 92301802T ES 92301802 T ES92301802 T ES 92301802T ES 2139588 T3 ES2139588 T3 ES 2139588T3
Authority
ES
Spain
Prior art keywords
derivative
cyclopropane
elevated
independently
cyclopropanic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92301802T
Other languages
English (en)
Inventor
Satoshi Hatsuya
Takaaki Sekiyama
Takashi Tsuji
Satoshi Iwayama
Masahiko Okunishi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ajinomoto Co Inc
Original Assignee
Ajinomoto Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ajinomoto Co Inc filed Critical Ajinomoto Co Inc
Application granted granted Critical
Publication of ES2139588T3 publication Critical patent/ES2139588T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/18—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one oxygen and one nitrogen atom, e.g. guanine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Abstract

UN DERIVADO CICLOPROPANO DE LA FORMULA (I) EN LA QUE B ELEVADO 1 ES UN RESIDUO DE PURINA O PIRIMIDINA, R ELEVADO 1 Y R (AL CUADRADO) SON, INDEPENDIENTEMENTE, HIDROGENO O UN GRUPO PROTECTOR PARA EL HIDROXIL Y CADA UNO DE K, M Y N REPRESENTA, INDEPENDIENTEMENTE, UN ENTERO DE 1 A 2, QUE ES UTIL POR SU EFECTO ANTIVIRAL.
ES92301802T 1991-03-05 1992-03-03 Derivado de ciclopropano. Expired - Lifetime ES2139588T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP12323991 1991-03-05
JP18470991 1991-07-24

Publications (1)

Publication Number Publication Date
ES2139588T3 true ES2139588T3 (es) 2000-02-16

Family

ID=26460224

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92301802T Expired - Lifetime ES2139588T3 (es) 1991-03-05 1992-03-03 Derivado de ciclopropano.

Country Status (9)

Country Link
US (2) US5342840A (es)
EP (1) EP0502690B1 (es)
JP (1) JP2923933B2 (es)
KR (1) KR100232619B1 (es)
AT (1) ATE187173T1 (es)
CA (1) CA2062299C (es)
DE (1) DE69230349T2 (es)
DK (1) DK0502690T3 (es)
ES (1) ES2139588T3 (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR950011530A (ko) * 1993-10-21 1995-05-15 도바 다다스 사이클로프로판 유도체 및 이를 함유하는 항바이러스제
TW282470B (es) * 1993-11-18 1996-08-01 Ajinomoto Kk
JP3769737B2 (ja) * 1994-03-30 2006-04-26 味の素株式会社 シクロプロパン誘導体及びその製造法
EP0845454A1 (en) * 1996-12-02 1998-06-03 Ajinomoto Co., Inc. Method for the production of optically active cyclopropane derivatives
JPH1129572A (ja) * 1997-07-10 1999-02-02 Ajinomoto Co Inc 核酸誘導体の精製法
JPH11255768A (ja) * 1998-03-09 1999-09-21 Ajinomoto Co Inc 抗ウイルス剤の製造方法
MY141789A (en) * 2001-01-19 2010-06-30 Lg Chem Investment Ltd Novel acyclic nucleoside phosphonate derivatives, salts thereof and process for the preparation of the same.
US7241890B2 (en) 2001-10-30 2007-07-10 Conforma Therapeutics Corporation Purine analogs having HSP90-inhibiting activity
JP2004026695A (ja) * 2002-06-24 2004-01-29 M's Science Corp 水性点眼用製剤
KR20060070572A (ko) 2003-09-18 2006-06-23 콘포마 세러퓨틱스 코포레이션 Ｈｓｐ90-저해제로서의 신규 헤테로시클릭 화합물
FR2864901B1 (fr) 2004-01-09 2007-10-05 Philippe Perovitch Composition pour le traitement au contact des hyposialies, incluant de la pilocarpine et a effets multiples
NZ561939A (en) 2005-03-30 2011-03-31 Conforma Therapeutics Corp Alkynyl pyrrolopyrimidines and related analogs as HSP90-inhibitors
DE102005053153B4 (de) * 2005-11-04 2007-07-19 Helmut Ristl Ristl-Getriebe
GB0814065D0 (en) * 2008-08-01 2008-09-10 Univ Leuven Kath Use of nucleoside analogs as anti-koi herpes virus molecules
EP2768799B1 (en) 2011-10-17 2019-08-07 Biotheryx Inc. Substituted biaryl alkyl amides
EP2776414B1 (en) * 2011-11-10 2016-03-16 Aratana Therapeutics NV Method for preparing cyclopropane derivatives
CN104144677B (zh) 2012-01-20 2016-11-23 阿拉塔纳医疗有限公司 滴眼剂组合物
CN104447749B (zh) * 2014-11-21 2016-06-01 河南师范大学 一种通过嘌呤对乙烯基环丙烷的选择性开环构建非环核苷的方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4016267A (en) * 1974-06-19 1977-04-05 Hoffmann-La Roche Inc. Sulfacytosine derivatives
US3923792A (en) * 1974-06-19 1975-12-02 Hoffmann La Roche Sulfacytosine derivatives
US4065480A (en) * 1975-06-12 1977-12-27 The Procter & Gamble Company Process for preparing substituted cyclopropycarbinyl compounds
CA1150299A (en) * 1978-08-17 1983-07-19 Pieter A. Verbrugge Intermediates in the preparation of cyclopropane-carboxylate esters and process for their manufacture
SE7810947L (sv) * 1978-10-20 1980-04-21 Draco Ab 3-alkylxanthines
US4859680A (en) * 1984-04-10 1989-08-22 Merck & Co., Inc. Pyrimidine derivatives as antiviral compounds
US4617304A (en) * 1984-04-10 1986-10-14 Merck & Co., Inc. Purine derivatives
US4714777A (en) * 1984-06-21 1987-12-22 University Of Pittsburgh Cyclopropanone hydrate derivatives
US4782062A (en) * 1987-05-11 1988-11-01 Merck & Co., Inc. 9-(2-hydroxymethyl)cycloalkylmethyl) guanines
DE3869299D1 (de) * 1987-09-24 1992-04-23 Mitsubishi Chem Ind Verfahren zur herstellung eines cycloalkanols.
US5126345A (en) * 1988-03-30 1992-06-30 E. R. Squibb & Sons, Inc. Bis (hydroxymethyl) cyclobutyl triazolopyrimidines
US5208388A (en) * 1988-07-19 1993-05-04 Bayer Aktiengesellschaft 2,2-difluorocyclopropyl derivatives
DE3824432A1 (de) * 1988-07-19 1990-03-22 Bayer Ag 2,2-difluorcyclopropyl-derivate
US4918075A (en) * 1988-12-20 1990-04-17 E. R. Squibb & Sons, Inc. Purinyl and pyrimidinyl cyclobutanes and their use as antiviral agents
US4988703A (en) * 1989-05-22 1991-01-29 Abbott Laboratories Carbocyclic nucleoside analogs with antiviral activity
US5064961A (en) * 1989-12-18 1991-11-12 E. R. Squibb & Sons, Inc. Process for preparing an optically active cyclobutane nucleoside
US5095136A (en) * 1990-08-27 1992-03-10 E. R. Squibb & Sons, Inc. Method for preparing isoprenoid cyclopropane 1,1-dicarboxylates and derivatives thereof and novel intermediates
DE4222497A1 (de) * 1992-07-09 1994-01-13 Huels Chemische Werke Ag Verfahren zur Herstellung von chlorfreiem Cyclopropancarbonsäuremethylester

Also Published As

Publication number Publication date
DE69230349D1 (de) 2000-01-05
DE69230349T2 (de) 2000-07-27
JP2923933B2 (ja) 1999-07-26
EP0502690B1 (en) 1999-12-01
DK0502690T3 (da) 2000-05-22
EP0502690A3 (en) 1992-12-09
CA2062299C (en) 1999-05-25
KR100232619B1 (ko) 1999-12-01
KR920018052A (ko) 1992-10-21
US5449840A (en) 1995-09-12
EP0502690A2 (en) 1992-09-09
JPH0578357A (ja) 1993-03-30
US5342840A (en) 1994-08-30
CA2062299A1 (en) 1992-09-06
ATE187173T1 (de) 1999-12-15

Similar Documents

Publication Publication Date Title
ES2139588T3 (es) Derivado de ciclopropano.
ES2183847T3 (es) Composiciones a base de agua que contienen organopolisiloxano, procedimiento para su elaboracion y su uso.
ES2085876T3 (es) Derivado de bifenilmetano, su utilizacion y composiciones farmacologicas que contienen el mismo.
ES2160237T3 (es) O-carbamoil-fenilalaninol que tiene sustituyente en anillo de benceno, sus sales farmaceuticamente utiles, y metodo para la preparacion de los mismos.
ATE137125T1 (de) Verfahren und anlage für brandschutz
NO955000D0 (no) Organopolysiloksan-holdige, vannbaserte sammensetninger, fremgangsmåte til fremstilling av sammensetningene og anvendelse av dem
AR241025A2 (es) Dispersiones de brillo perlino no ionicas, capaces de fluir"
ES2088574T3 (es) Derivado de anilida.
ES2157885T3 (es) Derivados de pirimidina o de triazina y composicion herbicida que los contiene.
ES2046196T3 (es) Derivados de azacicloalcanos, promotores de absorcion que contienen los derivados como ingrediente eficaz y preparaciones externas que contienen los promotores de absorcion.
ES2166374T3 (es) Composiciones de derivados de polifenoles y su preparacion.
CO5280223A1 (es) Nuevos compuestos
AU530900B2 (en) Pressure sensitive marking paper
ES2189942T3 (es) Sintesis de nucleosidos aciclicos.
ES2030013T3 (es) Procedimiento para producir un nuevo compuesto que tiene base de hipoxantina.
ATE12774T1 (de) Amin-carboxyborane mit pharmakologischer wirkung.
ES2059625T3 (es) Un procedimiento para preparar un derivado de hidroxialquilcisteina.
ES2180751T3 (es) Inhibidor de metastasis de cancer.
ES2059767T3 (es) Derivado de 1,4-dihidropiridina.
ES2181016T3 (es) Nuevos derivados de la eritromicina, su procedimiento de preparacion y su aplicacion como medicamentos.
ES2053018T3 (es) Tetrapeptido ciclico y procedimiento para su preparacion.
ES2088949T3 (es) Derivados de imidazolidina, su procedimiento de preparacion y pesticidas que los contienen.
ES2036583T3 (es) Iminooxazolidinas, procedimiento de preparacion y metodo de uso.
ES2096569T3 (es) Procedimiento para la obtencion de pirrolidin-2-onas n-substituidas.
ES2093125T3 (es) Derivados de alfa-metilenciclopentanona y su procedimiento de preparacion.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 502690

Country of ref document: ES